Early Access — free while we kick the tires
EdgarHawk

FCUV FOCUS UNIVERSAL INC. Insider Trading

4 filings analyzed · Latest 2025-08-15
Insider buys
4
Insider sells
0
Unique insiders
2
Direction
Net buying

Historically, high-priority insider buys have outperformed the S&P 500 by a median ~2% over the 30 days after filing — the edge is concentrated in that first month (n ≈ 5,751, 2021-2026). Past results don't predict the future. How we measure this ↗

August 2025
2025-08-15
high
CEO and Director
11,000 shares
$24,540
@ $2.23
Significance 7/10

CEO Wang Desheng bought 11,000 shares ($24,540) at $2.23 avg; FCUV down -76.9% from 52-week high; 5 prior buys at this ticker all well-timed at 90-day mark

CEO and Director Wang Desheng executed 11 separate open-market purchases totaling 11,000 shares for $24,540.00 on 2025-08-15 at a blended average price of $2.23, increasing his holdings to 2,273,800 shares. The stock is currently trading at $22.40, down -76.9% from its 52-week high of $97.00 and down -38.9% over the past 30 days. Notably, his 5 prior purchases at FCUV demonstrate a perfect 90-day win-rate pattern—all previous buys preceded upward price moves—suggesting demonstrated market-timing ability specific to this ticker. Against this backdrop, the company faces material headwinds: net income was $-1,505,648.00 in the latest quarter and the full-year result was unprofitable, with annual revenue contracting -62.2% year-over-year. This filing presents a tension between a historically well-timed buyer making a material accumulation move and a company experiencing significant financial deterioration.

September 2024
2024-09-18
high
CEO and Director
1,000,000 shares
$300,000
@ $0.30
Significance 6/10

FCUV CEO Wang Desheng buys 1.00M shares at $0.30 (21 Sept 2024); stock surges +80.9% in 30 days, now $35.10

CEO Wang Desheng purchased 1,000,000 shares of FOCUS UNIVERSAL INC. at $0.30 on 2024-09-18, increasing his holdings by 4.6% to 22.73M shares. The purchase occurred at an extreme discount to the current price of $35.10, now 83.8% below the 52-week high of $217.00—a dramatic valuation gap. Over the subsequent 30 days, the stock rallied +80.9%, while the 90-day return stands at +45.3%, significantly outpacing the purchase price. However, the company remains deeply unprofitable with a net loss of $1,365,106.00 in the latest quarter and only $19,753.00 in quarterly revenue, despite annual revenue growth of +197.6%. The CEO's five prior buys at FCUV (all on 2024-08-28) remain too recent to measure outcomes, and his cross-ticker track record shows 17 prior buys but no measurable timing signal at this specific ticker.

2024-09-18
high
President and Director
1,000,000 shares
$300,000
@ $0.30
Significance 6/10

President Lee Edward Shihai buys 1,000,000 shares of FCUV at $0.30 on 2024-09-18; holdings rise to 9.18M shares (+12.2%).

President and Director Lee Edward Shihai purchased 1,000,000 shares at $0.30, expanding his holdings by 12.2% to 9.18M shares. The transaction occurs against a background of extreme volatility: the stock currently trades at $35.10, down 83.8% from its 52-week high of $217.00 but up 80.9% over the past 30 days and 45.3% over 90 days. FCUV reports a market cap of $2.3B and annual revenue growth of 197.6%, yet remains operationally unprofitable with net income of $-1.4M in the most recent full fiscal year and quarterly revenue of only $19.8K. The disconnect between scale (market cap), growth narrative (197.6% annual revenue expansion), and economic fundamentals (massive losses, minimal quarterly revenue) creates material uncertainty about valuation sustainability and operational reality that warrant investor scrutiny of the company's financial trajectory.

August 2024
2024-08-29
high
CEO and Director
302,100 shares
$54,498
@ $0.18
Significance 7/10

CEO Wang Desheng purchases 302,100 shares across 17 transactions for $54,498.00 at $0.18 blended average as stock falls 91.2% from $217.00 peak.

Wang Desheng, CEO and Director, executed 17 separate open-market purchases totaling 302,100 shares for $54,498.00 between August 27–28, 2024, at prices ranging from $0.17 to $0.19 per share. This acquisition occurred while FCUV traded at extreme lows: the current price of $19.01 is 91.2% below the 52-week high of $217.00, and the stock has declined 22.0% in the past 30 days and 18.1% over 90 days. The company reported annual revenue growth of 197.6% but remains unprofitable, with net income of $-1,365,106.00 in the latest quarter against quarterly revenue of $19,753.00. The purchases represent a 1.4% increase in Wang's holdings, bringing his post-transaction position to 21,898,650 shares. The large magnitude, rapid execution across two consecutive days at depressed prices, and CEO-level commitment during a period of severe stock price deterioration warrant investor scrutiny regarding the company's operational trajectory and Wang's confidence in the turnaround prospects.

More Measuring and Controlling Instruments companies

Get alerts for FCUV

Add FCUV to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access